SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-029419
Filing Date
2019-08-06
Accepted
2019-08-06 16:45:31
Documents
56
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q tptx-10q_20190630.htm 10-Q 1994176
2 EX-31.1 tptx-ex311_11.htm EX-31.1 20971
3 EX-31.2 tptx-ex312_10.htm EX-31.2 19834
4 EX-32.1 tptx-ex321_9.htm EX-32.1 9557
5 EX-32.2 tptx-ex322_8.htm EX-32.2 9554
  Complete submission text file 0001564590-19-029419.txt   5527861

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT tptx-20190630.xml EX-101.INS 1013647
7 XBRL TAXONOMY EXTENSION SCHEMA tptx-20190630.xsd EX-101.SCH 36325
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE tptx-20190630_cal.xml EX-101.CAL 38578
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tptx-20190630_def.xml EX-101.DEF 97338
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE tptx-20190630_lab.xml EX-101.LAB 308775
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tptx-20190630_pre.xml EX-101.PRE 222935
Mailing Address 10628 SCIENCE CENTER DRIVE, SUITE 200 SAN DIEGO CA 92121
Business Address 10628 SCIENCE CENTER DRIVE, SUITE 200 SAN DIEGO CA 92121 858-926-5251
Turning Point Therapeutics, Inc. (Filer) CIK: 0001595893 (see all company filings)

IRS No.: 463826166 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38871 | Film No.: 191002757
SIC: 2834 Pharmaceutical Preparations